MEDBOX | Toolbox Research & Pipeline

TOOLBOX

Advanced search

Create your MEDBOX

TOOLBOX

Advanced search

Create your MEDBOX

LIST OPTIONS

FILTER BY LANGUAGE

FILTER BY COUNTRY

SORT BY

RESULTS/PAGE

LIST TYPE

26 records

	Evaluation of COVID-19 vaccine effectiveness in a changing landscape of COVID-19 epidemiology and vaccination World Health Organization WHO (2022) C_WHO View PDF(34) Download (19) Add to my MEDBOX Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine methodology issues there are still insufficient data to make a recommendation, in which case different options for approaching VE evaluations are presented Tags: Vaccination, COVID-19, effectiveness, evaluation, Source: https://apps.who.int/iris/bitstream/hand
	COVID-19 vaccine tracker and landscape World Health Organization WHO (2022) C_WHO Open external link (835) Add to my MEDBOX The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline. The COVID-19 vaccine tracker: Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-clinical development; Provides analysis and visualization for several COVID-19 vaccine candidate categories; Tracks the progress of each vaccine from pre-clinical, Phase 1, Phase 2 through to Phase 3 efficacy studies and including Phase 4 registered as interventional studies; Provides links to published reports on safety, immunogenicity and efficacy data of the vaccine candidates; Includes information on key attributes of each vaccine candidate and Allows users to search for COVID-19 vaccines through various criteria such as vaccine platform, schedule of vaccination, route of administration, developer, trial phase and clinical endpoints. The database is updated regularly - twice a week (Tuesday and Friday, 17:00 CET) Tags: vaccine, research, COVID-19, updates, vaccine candidates, vaccine trial, Source: https://www.who.int/publications/m/item/
	WHO’s Science in 5 Episode #70 - Upcoming new vaccines World Health Organization WHO (2022) C_WHO Open external link (413) Add to my MEDBOX 29 April 2022 What are the new vaccines in the pipeline? What are the challenges to turning vaccines into vaccination ? What timelines can we expect for future vaccines? WHO’s Dr Katherine O’Brien explains in Science in 5 Tags: Vaccination, Immunization, research, pipeline, COVID-19, general public, Video, Source: https://youtu.be/h8CVs3yYXwA
	Vaccines/COVID-19 vaccine EUL issued World Health Organization WHO (2022) C_WHO Open external link (380) Add to my MEDBOX This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize the efficiency of assessment, review and authorizations of medical products. Vaccines are undoubtedly the most complex medical products to develop, from concept to a stage where sufficient evidence of quality, safety and efficacy are collected to provide an assurance that their use will provide more benefits than risks when used in the context of a public health emergency Tags: vaccine candidates, COVID-19, recommendations, submission, quality data, Emergency Use Authorization, emergency use, Source: https://extranet.who.int/pqweb/vaccines/
	Coronavirus Vaccine Tracker Zimmer, C, J. Corum and S. Wee New York Times (2022) CC Open external link (945) Add to my MEDBOX Tags: vaccine, research, COVID-19, approval, development, Source: https://www.nytimes.com/interactive/2020
	Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process World Health Organization WHO (2021) C_WHO View PDF(294) Download (469) Add to my MEDBOX 15 Dec 2021 Tags: vaccine, candidates, vaccine candidates, COVID-19, WHO, Source: https://extranet.who.int/pqweb/sites/def
	FAQ COVID-19-Impfstoffe Entwicklung und Zulassung Paul Ehrlich Institute (2021) CC Open external link (698) Add to my MEDBOX Ausführliche Informationen zu klinischen Prüfungen und Risiken für bestimmte Gruppe sowie zu Wechselwirkungen und Nebenwirkungen. Tags: Imfpung, COVID-19, SARS-CoV-2, Impfstoffe, Impfentwicklung, mRNA, Sicherheit, Risikogruppen, Nebenwirkungen, Source: https://www.pei.de/DE/newsroom/dossier/c
	Vacunas Kamradt, T., B.S. Kamps J. García-Rosales Delgado (2021) CC Open external link (439) Add to my MEDBOX COVID Reference 23 May 2021 Tags: vaccine candidates, COVID-19, SARS-CoV-2, mRNA, Moderna, pfizer, Astra Zeneca, development, vaccine trial, Scientific Updates, Source: https://covidreference.com/Vaccines_es
	Vaccines Kamradt, T., and B.S. Kamps (2021) CC Open external link (510) Add to my MEDBOX COVID Reference 23 May 2021 Tags: vaccine candidates, COVID-19, SARS-CoV-2, mRNA, Moderna, pfizer, Astra Zeneca, development, vaccine trial, Scientific Updates, Source: https://covidreference.com/vaccines
	Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 World Health Organization WHO (2021) C_WHO View PDF(26) Download (18) Add to my MEDBOX Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respiratory Infection (SARI) to estimate COVID-19 vaccine effectiveness (VE) in preventing SARI associated with laboratory-confirmed SARS-CoV-2 using existing SARI surveillance systems. The approach uses the test-negative design to evaluate VE; cases are SARI patients who tested positive for SARS-CoV-2, and controls are SARI patients who tested negative for SARS-CoV-2 Tags: COVID-19, vaccine, effectiveness, SARS-CoV-2, study, Source: https://apps.who.int/iris/rest/bitstream

26 records

26 records